110 related articles for article (PubMed ID: 16263093)
1. Increased lysosomal uptake of methotrexate-polyglutamates in two methotrexate-resistant cell lines with distinct mechanisms of resistance.
Marshall LA; Rhee MS; Hofmann L; Khodjakov A; Schneider E
Biochem Pharmacol; 2005 Dec; 71(1-2):203-13. PubMed ID: 16263093
[TBL] [Abstract][Full Text] [Related]
2. Lack of an effect of breast cancer resistance protein (BCRP/ABCG2) overexpression on methotrexate polyglutamate export and folate accumulation in a human breast cancer cell line.
Rhee MS; Schneider E
Biochem Pharmacol; 2005 Jan; 69(1):123-32. PubMed ID: 15588721
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the facilitated transport of methotrexate polyglutamates into lysosomes derived from S180 cells. Basic properties and specificity for polyglutamate chain length.
Barrueco JR; Sirotnak FM
J Biol Chem; 1991 Jun; 266(18):11732-7. PubMed ID: 1711038
[TBL] [Abstract][Full Text] [Related]
4. Metabolic turnover of methotrexate polyglutamates in lysosomes derived from S180 cells. Definition of a two-step process limited by mediated lysosomal permeation of polyglutamates and activating reduced sulfhydryl compounds.
Barrueco JR; O'Leary DF; Sirotnak FM
J Biol Chem; 1992 Aug; 267(22):15356-61. PubMed ID: 1379226
[TBL] [Abstract][Full Text] [Related]
5. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E
Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481
[TBL] [Abstract][Full Text] [Related]
6. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Diddens H; Niethammer D; Jackson RC
Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
[TBL] [Abstract][Full Text] [Related]
7. Facilitated transport of methotrexate polyglutamates into lysosomes derived from S180 cells. Further characterization and evidence for a simple mobile carrier system with broad specificity for homo- or heteropeptides bearing a C-terminal glutamyl moiety.
Barrueco JR; O'Leary DF; Sirotnak FM
J Biol Chem; 1992 Oct; 267(28):19986-91. PubMed ID: 1383199
[TBL] [Abstract][Full Text] [Related]
8. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
Rhee MS; Galivan J; Wright JE; Rosowsky A
Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
[TBL] [Abstract][Full Text] [Related]
9. Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.
Pizzorno G; Mini E; Coronnello M; McGuire JJ; Moroson BA; Cashmore AR; Dreyer RN; Lin JT; Mazzei T; Periti P
Cancer Res; 1988 Apr; 48(8):2149-55. PubMed ID: 2450647
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates.
Barakat RR; Li WW; Lovelace C; Bertino JR
Gynecol Oncol; 1993 Oct; 51(1):54-60. PubMed ID: 7694891
[TBL] [Abstract][Full Text] [Related]
11. Impairment of methotrexate (MTX)-polyglutamate formation of MTX-resistant K562 cell lines.
Koizumi S
Jpn J Cancer Res; 1988 Nov; 79(11):1230-7. PubMed ID: 2465288
[TBL] [Abstract][Full Text] [Related]
12. Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate.
Curt GA; Jolivet J; Carney DN; Bailey BD; Drake JC; Clendeninn NJ; Chabner BA
J Clin Invest; 1985 Oct; 76(4):1323-9. PubMed ID: 2414316
[TBL] [Abstract][Full Text] [Related]
13. Role of methotrexate polyglutamates in methotrexate- and sequential methotrexate-5-fluorouracil-mediated cell kill.
McGuire JJ; Mini E; Hsieh P; Bertino JR
Cancer Res; 1985 Dec; 45(12 Pt 1):6395-400. PubMed ID: 2415244
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
Kuehl M; Brixner DI; Broom AD; Avery TL; Blakley RL
Cancer Res; 1988 Mar; 48(6):1481-8. PubMed ID: 2449950
[TBL] [Abstract][Full Text] [Related]
15. Wild-type and drug-resistant Leishmania major hydrolyze methotrexate to N-10-methyl-4-deoxy-4-aminopteroate without accumulation of methotrexate polyglutamates.
Ellenberger TE; Wright JE; Rosowsky A; Beverley SM
J Biol Chem; 1989 Sep; 264(27):15960-6. PubMed ID: 2476435
[TBL] [Abstract][Full Text] [Related]
16. The kinetics of methotrexate polyglutamation in human breast cancer cells.
Morrison PF; Allegra CJ
Arch Biochem Biophys; 1987 May; 254(2):597-610. PubMed ID: 2437860
[TBL] [Abstract][Full Text] [Related]
17. Role of polyglutamates in methotrexate action.
Wilmanns W; Schalhorn A
Chemioterapia; 1985 Oct; 4(5):349-53. PubMed ID: 2416481
[TBL] [Abstract][Full Text] [Related]
18. A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates.
Cowan KH; Jolivet J
J Biol Chem; 1984 Sep; 259(17):10793-800. PubMed ID: 6206061
[TBL] [Abstract][Full Text] [Related]
19. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
20. Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II).
Rosowsky A; Wright JE; Cucchi CA; Flatow JL; Trites DH; Teicher BA; Frei E
Cancer Res; 1987 Nov; 47(22):5913-8. PubMed ID: 3664492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
